Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging Trial
Phase: PHASE1 | Sponsor: Medical University of Vienna | Compound: Psilocybin
- Status
- recruiting
- Institution
- Medical University of Vienna
- Start date
- 2025-11-01
- End date
- 2028-05-31
- Registry ID
- NCT07490353
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.